Literature DB >> 2090280

A case-control study of diet and risk of renal adenocarcinoma.

M Maclure1, W Willett.   

Abstract

We examined dietary and other risk factors for renal adenocarcinoma in a case-control study of 203 incident and 207 prevalent cases and 605 neighborhood controls. Using unconditional logistic regression to control selection biases identified in an adjunct study, we found exposure odds ratios (OR) similar to those from other studies: 1.9 (with a 95% confidence interval (Cl) from 0.8 to 4.4) for smoking 2 packs of cigarettes per day; 3.8 (95% Cl: 0.78-18) for 3 or more packs per day; 1.7 (95% Cl: 0.9-3.2) for women and 1.7 (95% Cl: 1.1-2.8) for men in the highest quintile of relative weight (kg/m2); 2.0 (95% Cl: 1.3-3.1) for northeastern European ancestry; and 2.3 (95% Cl: 1.3-4.1) for history of kidney stones. Incident cases consumed more meats and fewer vegetables than controls: the age-sex-education-adjusted OR for average intake of 85 g (3 oz) of beef per day was 3.4 (95% Cl: 1.6-7.2). Inverse associations were seen for most vegetables. Dietary animal protein, animal fat, and saturated fat, with and without energy adjustment, were weakly associated with disease in unconditional and conditional logistic regressions. Prior hypotheses concerning intake of cholesterol, beta-carotene, preformed vitamin A, and cruciferous vegetables were not corroborated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2090280     DOI: 10.1097/00001648-199011000-00004

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  30 in total

1.  Predictive factors for response to treatment in patients with advanced renal cell carcinoma.

Authors:  Carolina Muriel López; Emilio Esteban; Aurora Astudillo; Pablo Pardo; Jose Pablo Berros; Marta Izquierdo; Guillermo Crespo; Paula J Fonseca; Miguel Sanmamed; Pablo Martínez-Camblor
Journal:  Invest New Drugs       Date:  2012-05-27       Impact factor: 3.850

2.  Risk factors for renal cell carcinoma: results of a population-based case-control study.

Authors:  N Kreiger; L D Marrett; L Dodds; S Hilditch; G A Darlington
Journal:  Cancer Causes Control       Date:  1993-03       Impact factor: 2.506

3.  Metabolic features of clear-cell renal cell carcinoma: mechanisms and clinical implications.

Authors:  Jehonathan H Pinthus; Kaitlyn F Whelan; Daniel Gallino; Jian-Ping Lu; Nathan Rothschild
Journal:  Can Urol Assoc J       Date:  2011-08       Impact factor: 1.862

4.  A population-based study on the association between urinary calculi and kidney cancer.

Authors:  Shiu-Dong Chung; Shih-Ping Liu; Herng-Ching Lin
Journal:  Can Urol Assoc J       Date:  2013 Nov-Dec       Impact factor: 1.862

5.  Risk factors for renal cell cancer in a Japanese population.

Authors:  Masakazu Washio; Mitsuru Mori
Journal:  Clin Med Oncol       Date:  2009-06-15

6.  Risk factors for renal cell carcinoma in Denmark. I. Role of socioeconomic status, tobacco use, beverages, and family history.

Authors:  A Mellemgaard; G Engholm; J K McLaughlin; J H Olsen
Journal:  Cancer Causes Control       Date:  1994-03       Impact factor: 2.506

7.  Dietary fat and risk of renal cell carcinoma in the USA: a case-control study.

Authors:  Kaye E Brock; Gloria Gridley; Brian C-H Chiu; Abby G Ershow; Charles F Lynch; Kenneth P Cantor
Journal:  Br J Nutr       Date:  2008-09-12       Impact factor: 3.718

Review 8.  Nutrition and renal cell cancer.

Authors:  A Wolk; P Lindblad; H O Adami
Journal:  Cancer Causes Control       Date:  1996-01       Impact factor: 2.506

9.  Renal cell carcinoma and thiazide use: a historical, case-control study (California, USA).

Authors:  R A Hiatt; K Tolan; C P Quesenberry
Journal:  Cancer Causes Control       Date:  1994-07       Impact factor: 2.506

10.  Fish, vitamin D, and flavonoids in relation to renal cell cancer among smokers.

Authors:  Robin Taylor Wilson; Jiangyue Wang; Vernon Chinchilli; John P Richie; Jarmo Virtamo; Lee E Moore; Demetrius Albanes
Journal:  Am J Epidemiol       Date:  2009-08-03       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.